Literature DB >> 10920782

Plasma and urinary trypsinogen activation peptide in healthy dogs, dogs with pancreatitis and dogs with other systemic diseases.

C S Mansfield1, B R Jones.   

Abstract

OBJECTIVE: To determine the specificity and sensitivity of plasma and urinary trypsinogen activation peptide (TAP) concentrations in diagnosing pancreatitis in dogs.
DESIGN: Retrospective analysis of clinical cases. PROCEDURE: Dogs were classified into three groups: healthy animals, dogs with confirmed pancreatitis and dogs with nonpancreatic disease, which clinically or biochemically resembled pancreatitis. This last group was further subdivided into dogs with renal and those with nonrenal disease. The plasma and urinary TAP concentration was determined by a competitive enzyme immunoassay. Clinical cases additionally had serum trypsin-like immunoreactivity concentration measured, as well as radiography and ultrasound of the abdomen and further diagnostic procedures. Nonparametric analysis of variance (Kruskal-Wallis test) was performed using Statistix 4.0 program.
RESULTS: There was a wide range of urinary TAP concentration in healthy dogs (mean 52.30 nmol/L, standard deviation 55.25) that made interpretation of urinary TAP concentrations difficult in the other groups. There was a narrow reference range for plasma TAP (mean 2.67 nmol/L, standard deviation 0.93). Plasma and urinary TAP concentrations, as well as urinary TAP to creatinine ratio, were all increased in dogs that died with necrotising pancreatitis. Values were not increased in mild, interstitial pancreatitis. Increased plasma TAP concentrations were also present in dogs with severe renal disease.
CONCLUSION: Plasma TAP concentration is a good prognostic indicator in naturally occurring pancreatitis in dogs. The failure of TAP to increase in mild pancreatitis, and the increase present in severe renal disease, suggests its measurement has limited application as a sole diagnostic tool for canine pancreatitis. Further investigations are required in order to explain the large variability of urinary TAP concentration and the presence of circulating TAP in healthy dogs.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10920782     DOI: 10.1111/j.1751-0813.2000.tb11833.x

Source DB:  PubMed          Journal:  Aust Vet J        ISSN: 0005-0423            Impact factor:   1.281


  6 in total

1.  Serum and urine concentrations of trypsinogen-activation peptide as markers for acute pancreatitis in cats.

Authors:  Heidi S Allen; Jörg Steiner; John Broussard; Caroline Mansfield; David A Williams; Boyd Jones
Journal:  Can J Vet Res       Date:  2006-10       Impact factor: 1.310

Review 2.  Laboratory tests for diagnosis of gastrointestinal and pancreatic diseases.

Authors:  Olivier Dossin
Journal:  Top Companion Anim Med       Date:  2011-05

3.  Evaluation of 1,2-O-dilauryl-rac-glycero glutaric acid-(6'-methylresorufin) ester (DGGR) and 1,2-diglyceride lipase assays in dogs with naturally occurring hypercortisolism.

Authors:  Guido Linari; Francesco Dondi; Sofia Segatore; Kateryna Vasylyeva; Nikolina Linta; Marco Pietra; Rodolfo O Leal; Federico Fracassi
Journal:  J Vet Diagn Invest       Date:  2021-06-02       Impact factor: 1.569

4.  Agreement of serum Spec cPL with the 1,2-o-dilauryl-rac-glycero glutaric acid-(6'-methylresorufin) ester (DGGR) lipase assay and with pancreatic ultrasonography in dogs with suspected pancreatitis.

Authors:  P H Kook; N Kohler; S Hartnack; B Riond; C E Reusch
Journal:  J Vet Intern Med       Date:  2014-03-05       Impact factor: 3.333

5.  Prognostic value of canine pancreatic lipase immunoreactivity and lipase activity in dogs with gastric dilatation-volvulus.

Authors:  Giuseppe Spinella; Francesco Dondi; Lisa Grassato; Luca Magna; Veronica Cola; Massimo Giunti; Sara Del Magno; Simona Valentini
Journal:  PLoS One       Date:  2018-09-18       Impact factor: 3.240

6.  Effect of prednisolone therapy on serum levels of 1,2-O-dilauryl-rac-glycero glutaric acid-(6'-methylresorufin) ester lipase in dogs.

Authors:  Beatriz Mendoza; Maria Joana Dias; Telmo Nunes; Maria Alexandra Basso; Juan Hernandez; Rodolfo Oliveira Leal
Journal:  J Vet Intern Med       Date:  2020-11-04       Impact factor: 3.333

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.